Advances in Therapy
ISSN 0741-238x · Adis, Springer Healthcare · United Kingdom · active 1984–2026
Metrics
- Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 4.2
- SJR
- 1.418
- h-index
- 115
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 25 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Advances in Therapy is Q1 in all 2 of its subject categories.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Pharmacology (medical) | Q1 | #34 of 286 |
| Medicine (miscellaneous) | Q1 | #276 of 2,517 |
- Cites per document (2 years, Scopus)
- 4.52
- Documents indexed in 2025 (Scopus)
- 375
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Advances in Therapy is Q1 in all 2 of its Scimago subject categories (2025 edition; best category Pharmacology (medical): Q1, #34 of 286), with SJR 1.418 (Scimago) and an h-index of 115 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to acceptance
- 74 days (median)Estimated from our library (11 papers)
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- hybrid. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Advances in Therapy a predatory journal?
Our screening does not flag Advances in Therapy. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Advances in Therapy indexed in Scopus or Web of Science?
Per our venue index, Advances in Therapy appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Advances in Therapy?
Papers in Advances in Therapy are cited about 4.2 times each within two years of publication, and Scimago places it in Q1, with an h-index of 115. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Advances in Therapy (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Advances in Therapy is Q1 in all 2 of its subject categories. By category: Pharmacology (medical): Q1, #34 of 286; Medicine (miscellaneous): Q1, #276 of 2,517. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Advances in Therapy is cited about 4.2 times per paper over two years, with an h-index of 115.
What is the Web of Science (JCR) quartile of Advances in Therapy?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Advances in Therapy. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Advances in Therapy open access?
Our index records its access status as "hybrid". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
How long does Advances in Therapy take to publish a paper?
Submission to acceptance for Advances in Therapy takes about 74 days (median) — Estimated from our library (n=11 papers). Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Advances in Therapy.
Ready to submit? Tools for your next paper
Similar venues
Compare it with its peers: Ranked Endocrinology, Diabetes and Metabolism journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.